Shastri Suresh G, Sancheti Pooja, Nagaraja Sharath Burugina, Dayananda Gagana G, Srinivas Pujari K, Jayaprakash Murugesh, Ninge Gowda Shivashankara N, Krishnamurthy Aditi, Srinivasa Balu P, Singarajipura Anil, Devendiran Randeep
AB-ArK Cell, Commissionerate of Health & Family Welfare Services, Bangalore, Karnataka, India.
Department of Community Medicine, ESIC Medical College and PGIMSR, Bengaluru, India.
Lancet Reg Health Southeast Asia. 2023 Nov 23;22:100327. doi: 10.1016/j.lansea.2023.100327. eCollection 2024 Mar.
The WHO's "End TB" initiative aims to reduce catastrophic expenses, incidence, and mortality by 90%, 80%, and 0%, respectively by 2030 and Government of India has committed to reaching these goals by 2025. Despite tremendous progress, tuberculosis (TB) remains one of the main public health issues. To limit TB transmission and expedite reduction in incidence, further measures are needed. These milestones and objectives remain aspirational until we achieve "Universal access" to high-quality TB diagnosis and treatment. The goals of the study include outlining the process of 'Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana-Arogya Karnataka' (AB-PMJAY-ArK) integration with the National TB Elimination Program (NTEP) in Karnataka, the types of TB patients who used AB-PMJAY-ArK services, and calculating the cost per TB patient at primary, secondary, and tertiary healthcare facilities, both public and private, stratified by type of service. Increased coverage, elimination of treatment delays, early and free treatment, and prevention of missing patients are benefits of integrating NTEP with Ayushman Bharat-PMJAY.
世界卫生组织的“终止结核病”倡议旨在到2030年分别将灾难性支出、发病率和死亡率降低90%、80%和0%,印度政府已承诺到2025年实现这些目标。尽管取得了巨大进展,但结核病仍然是主要的公共卫生问题之一。为了限制结核病传播并加快发病率的降低,还需要采取进一步措施。在实现高质量结核病诊断和治疗的“普遍可及”之前,这些里程碑和目标仍只是理想状态。该研究的目标包括概述“阿育吠陀·巴拉特-总理民众健康保险计划-阿罗吉亚·卡纳塔克邦”(AB-PMJAY-ArK)与卡纳塔克邦国家结核病消除计划(NTEP)整合的过程、使用AB-PMJAY-ArK服务的结核病患者类型,以及计算公立和私立初级、二级和三级医疗机构中每位结核病患者的费用,并按服务类型分层。将NTEP与阿育吠陀·巴拉特-总理民众健康保险计划整合的好处包括扩大覆盖范围、消除治疗延误、实现早期免费治疗以及防止患者失访。